STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
STAT News · LC · trust 46/100
Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Read the original at STAT News →
Open in TruthVane →